艾迪药业,688488,收入构成,报告日期,2020-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医疗器械,5128,3580,1548,30.19%,10.69% 药品制造,2553,1543,1010,39.58%,6.98% 生物医药原辅料,21059,9265,11794,56%,81.46% 其他(补充),165,38,127,76.73%,0.87%